1. AEDO, A.R., LANDGREN, B.M., JOHANNISSON, E., and DICZFALUSY, E. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations. Contraception 31(5): 453-469. May 1985.
2. AFFANDI, B., KARMADIBRATA, S., PRIHARTONO, J., LUBIS, F., and SAMIL, R.S. Effect of Norplant on mothers and infants in the postpartum period. Advances in Contraception 2(4): 371-380. December 1986.
3. ALVAREZ, F., FAÚNDES, A., BRACHE, V., TEJADA, A.S., and SEGAL, S. Prospective study of the pituitary-ovarian function after tubal sterilization by the Pomeroy or Uchida techniques. Fertility and Sterility 51: 604-608. 1989.
4. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS. Safety of oral contraceptives for teenagers. Journal of Adolescent Health 13(4): 333-336. June 1992.
5. AMERICAN SOCIETY OF HOSPITAL PHARMACISTS (ASHP). American hospital formulary service drug information. Bethesda, Maryland, ASHP, 1994. p. 1208.
6. ANDRADE, A. and PIZARRO, E. Quantitative studies on menstrual blood loss in IUD users. Contraception 36(1): 129-144. July 1987.
7. ANGLE, M.A., BROWN, L.A., and BUEKENS, P. IUD protocols for international training. Studies in Family Planning 24(2): 125-131. March-April 1993.
8. ANONYMOUS. Cervical cap: Effective, convenient, but overlooked. Contraceptive Technology Update 11: 49-54. 1990.
9. ANONYMOUS. Drug facts and comparisons. St. Louis, Missouri, Wolters Kluwer. Facts and Comparisons, October 1990. p. 387a. and 1993. p. 251. and June 1996, p. 358. and July 1996. p. 282-284.
10. ANONYMOUS. Tests show commonly used substances harm latex condoms. Contraceptive Technology Update 10(2): 20-21. April 1989.
11. ARMSTRONG, K.A., SAMOST, L., and TAVRIS, D.R. HIV-risk behaviors of sterilized and nonsterilized women in drug treatment programs—Philadelphia, 1989-1991. Morbidity and Mortality Weekly Report 41(9): 149-151. March 6, 1992.
12. AUSTIN, H., LOUV, W.C., and ALEXANDER, W.J. A case-control study of spermicides and gonorrhea. Journal of the American Medical Association 251: 2822-2824. 1984.
13. AVSC INTERNATIONAL (AVSC). Minilaparotomy under local anesthesia: Service delivery guidelines. New York, AVSC, May 1996.
14. AVSC INTERNATIONAL (AVSC). No-scalpel vasectomy: A training course for vasectomy providers and assistants. New York, AVSC, 1997. (In press)
15. BACK, D.J., BRECKENRIDGE, A.M., GRIMER, S., ORME, M., and PURBA, H. Pharmacokinetics of oral contraceptive steroids following the administration of the anti-malarial drugs primaquine and chloroquine. Contraception 30(3): 289-295. 1984.
16. BACK, D.J. and ORME, M.L. Drug interactions. In: Goldzieher, J.W. and Fotherby, K., eds. Pharmacology of the contraceptive steroids. New York, Raven Press, 1994. p. 407-425.
17. BALL, M.J., ASHWELL, E., and GILLMER, M.D.G. Progestagen-only oral contraceptives: Comparison of the metabolic effects of levonorgestrel and norethisterone. Contraception 44: 223-233. 1991.
18. BASSOL, S. and GARZA-FLORES, J. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives. Contraception 49(5): 441-453. May 1994.
19. BASSOL, S., GARZA-FLORES, J., CRAVIOTO, M.C., DIAZ-SANCHEZ, V., FOTHERBY, K., LICHTENBERG, R., and PEREZ-PALACIOS, G. Ovarian function following a single administration of depo-medroxyprogesterone acetate (DMPA) at different doses. Fertility and Sterility 42(2): 216-222. 1984.
20. BELKER, A., THOMAS, A., FUCHS, E., KONNAK, J., and SHARLIP, I. Results of 1,469 microsurgical vasectomy reversals by the vasovasotomy study group. Journal of Urology 145: 505-511. 1991.
21. BELL, T.A. and GRAYSTON, J.T. Centers for Disease Control guidelines for prevention and control of Chlamydia trachomatis infections. Annals of Internal Medicine 104: 524-526. 1986.
22. BELLAGIO CONSENSUS CONFERENCE ON LACTATIONAL INFERTILITY. Bellagio consensus statement on the use of breastfeeding as a family planning method. Contraception 39(8): 477-496. 1989.
23. BELSEY, E.M. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 38(2): 207-225. August 1988.
24. BELSEY, E.M. Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Advances in Contraception 7(2-3): 257-270. June-September 1991.
25. BONJOUR, J.P., THEINTZ, G., BUCHS, B., SLOSMAN, D., and RIZZOLI, R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism 73: 555-563. 1991.
26. BORING, C.C., ROCHAT, R.W., and BECERRA, J. Sterilization regret among Puerto Rican women. Fertility and Sterility 49: 973-981. 1988.
27. BOUNDS, W., GUILLEBAUD, J., DOMINIK, R., and DALBERTH, B.T. The diaphragm with and without spermicide: A randomized comparative efficacy trial. Journal of Reproductive Medicine 40: 764-774. 1995.
28. BRACKEN, M.B. Oral contraception and congenital malformations in offspring: A review and meta-analysis of the prospective studies. Obstetrics and Gynecology 76(3, pt. 2): 552-557. September 1990.
29. BRACKEN, M.B., HELLENBRAND, K.G., and HOLFORD, T.R. Conception delay after oral contraceptive use: The effect of estrogen dose. Fertility and Sterility 58: 21-27. 1990.
30. BROWNLEE, H. and TIBBELS, C. Vasectomy. Journal of Family Practice 16(2): 279-284. 1983.
31. CASTILLA, E., SIMPSON, J., and QUEENAN, J. Down's syndrome is not increased in offspring of natural family planning users (case control analysis). American Journal of Medical Genetics 59(4): 525. 1995.
32. CATES, W., Jr. and HINMAN, A.R. AIDS and absolutism—The demand for perfection in prevention (sounding board). New England Journal of Medicine 327: 492-494. 1992.
33. CATES, W., Jr. and STONE, K.M. Family planning, sexually transmitted diseases and contraceptive choice: A literature update—Part 1. Family Planning Perspectives 24(2): 75-84. March-April 1992.
34. CHAUDHURY, R.R., CHOMPOOTAWEEP, S., DUSITSIN, N., FRIESEN, H., and TANKEYOON, M. The release of prolactin by medroxyprogesterone acetate in human subjects. British Journal of Pharmacology 59: 433-434. 1977.
35. CHESTER, A.H., JIANG, C., BORLAND, J.A., YACOUB, M.H., and COLLINS, P. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coronary Artery Disease 6: 417-422. 1995.
36. CHI, I.C. The safety and efficacy of progestin-only oral contraceptives—An epidemiological perspective. Contraception 47(1): 1-21. 1993.
37. CHI, I.C. and FARR, G. Postpartum IUD contraception—A review of an international experience. Advances in Contraception 5(3): 127-146. September 1989.
38. CHILVERS, C., MCPHERSON, K., PETO, J., PIKE, M.C., and VESSEY, M.P. Oral contraceptive use and breast cancer risk in young women. Lancet 1(8645): 973-982. May 6, 1989.
39. CHRETIEN, F.C., SUREAU, C., and NEAU, C. Experimental study of cervical blockage induced by continuous low-dose oral progestogens. Contraception 22: 445-456. 1980.
40. CHUTIVONGSE, S., GRAY, R., HILL, C., HULKA, B., KENYA, P., ODLIND, V., PARDTHAISONG, T., PETITTI, D., RUBIN, G., and SHAPIRO, S. Depot-medroxyprogesterone acetate (DMPA) and cancer: Memorandum from a WHO meeting. Bulletin of the World Health Organization 64(3): 375-382. 1986.
41. CLARKE, L. and GREGSON, S. Who has a vasectomy reversal? Journal of Biosocial Science 18: 253-269. 1986.
42. COHEN, B. and GIBOR, Y. Anemia and menstrual blood loss. Obstetrical and Gynecological Survey 35(10): 597-618. 1980.
43. COHEN, R.J., BROWN, K.H., CANAHUATI, J., RIVERA, L.L., and DEWEY, K.G. Effects of age of introduction of complementary foods on infant breast milk intake, total energy intake, and growth: A randomized intervention study in Honduras. Lancet 343: 288-293. 1994.
44. CONSORTIUM FOR EMERGENCY CONTRACEPTION (CEC). Emergency contraceptive pills. Welcome, Maryland, CEC, 1996.
45. COONEY, K.A., NYIRABUKEYE, T., LABBOK, M., HOSER, P., and BALLARD, E. Assessment of the nine-month Lactational Amenorrhea Method (MAMA-9) in Rwanda. Studies in Family Planning 24: 162-171. 1996.
46. COUTINHO, E.M., SPINOLA, P., IONE, B., et al. Multicenter, double-blind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contraceptive combination of 90 mg dihydroxyprogesterone acetophenide and 6 mg estradiol enanthate. Contraception 55: 175-181. 1997.
47. CRAMER, D.W., SCHIFF, I., SCHOENBAUM, S.C., et al. Tubal infertility and the intrauterine device. New England Journal of Medicine 312(15): 941-947. April 11, 1985.
48. CROXATTO, H.B. Norplant: Levonorgestrel-releasing contraceptive implant. Annals of Medicine 25: 155-160. 1993.
49. CUNNINGHAM, F.G., MACDONALD, P.C., LEVENO, K.J., GANT, N.F., and GILSTRAP, L.C. The puerperium. In: Williams Obstetrics. 19th ed. Norwalk, Connecticut, Appleton and Lange, 1993. p. 459-473.
50. D'ARCY, P.F. Drug interaction and reaction: Update: Drug interactions with oral contraceptives. Drug Intelligence and Clinical Pharmacy 20: 353-362. 1986.
51. DAHLMAN, T., HELLGREN, M., and BLOMBÄCK, M. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecologic and Obstetric Investigation 20(1): 37-44. 1985.
52. DARLING, J.R., WEISS, N.S., METCH, B.J., CHOW, W.H., SODERSTROM, R.M., MOORE, D.E., SPADONI, L.R., and STADEL, B.V. Primary tubal infertility in relation to use of an intrauterine device. New England Journal of Medicine 312(15): 937-941. 1985.
53. DARLING, J.R., WEISS, N.S., VOIGT, L.F., MCKNIGHT, B., and MOORE, D.E. The intrauterine device and primary tubal infertility. [Letter] New England Journal of Medicine 326(3): 203-204. 1992.
54. DECEULAER, K., GRUBER, C., HAYES, R., and SERJEANT, G.R. Medroxyprogesterone acetate and homozygous sickle cell disease. Lancet 2(8292): 229-231. July 31,1982.
55. DESLYPERE, J.P., THIERY, M., and VERMEULEN, A. Effect of long-term hormonal contraception on plasma lipids. Contraception 31(6): 633-642. June 1985.
56. DESTEFANO, F., PERLMAN, J.A., PETERSON, H.B., and DIAMOND, E.L. Long-term risk of menstrual disturbances after tubal sterilization. American Journal of Obstetrics and Gynecology 152(7, pt. 1): 835-841. August 1, 1995.
57. DEVINCENZI, I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. New England Journal of Medicine 331(6): 341-346. August 11, 1994.
58. DEWEY, K.G., PEERSON, J.M., BROWN, K.H., et al. Growth of breast-fed infants deviates from current reference data: A pooled analysis of US, Canadian, and European data sets. Pediatrics 96: 495-503. 1995.
59. DHUPER, S., WARREN, M.P., BROOKS-GUNN, J., and FOX, R. Effects of hormonal status on bone density in adolescent girls. Journal of Clinical Endocrinology and Metabolism 71(5): 1083-1088. November 1990.
60. DIAS, P. The long-term effects of vasectomy on sexual be- haviour. Acta Psychiatrica Scandinavica 67(5): 333-338. 1983.
61. DIAZ, S., CROXATTO, H.B., DAVEZ, M., BELHADJ, H., STERN, J., and SIVIN, I. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 42(1): 97-109. July 1990.
62. DIAZ, S., HERREROS, C., JUEZ, G., CASADO, M.E., SALVATIERRA, A.M., MIRANDA, P., PERALTA, O., and CROXATTO, H.B. Fertility regulation in nursing women: 7. Influence of Norplant levonorgestrel implants upon lactation and infant growth. Contraception 32(1): 53-74. July 1985.
63. DIAZ, S., PERALTA, O., JUEZ, G., HERREROS, C., CASADO, M., SALVATIERRA, A., MIRANDA, P., and CROXATTO, H. Fertility regulation in nursing women: 6. Contraceptive effectiveness of a subdermal progesterone implant. Contraception 30(4): 311-325. October 1984.
64. DIAZ, S., RODRIGUEZ, G., PERALTA, O., et al. Lactational amenorrhea and the recovery of ovulation and fertility in fully nursing Chilean women. Contraception 38(1): 53-67. July 1988.
65. DICKER, D., WACHSMAN, Y., and FELDBERG, D. The vaginal contraceptive diaphragm and the condom: A reevaluation and comparison of two barrier methods with the rhythm method. Contraception 40(4): 497-504. October 1989.
66. DIXON, G.W., SCHLESSELMAN, J.J., ORY, H.W., and BLYE, R.P. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. Journal of the American Medical Association 244: 1336-1339. 1980.
67. DREW, W.L., BLAIR, M., MINER, R.C., and CONANT, M. Evaluation of the virus permeability of a new condom for women. Sexually Transmitted Diseases 17: 110-112. 1990.
68. DUBUISSON, J., CHAPRON, C., NOS, C., et al. Sterilization reversal: Fertility results. Human Reproduction 10(5): 1145-1151. May 1995.
69. DUNSON, T.R., MCLAURIN, V.L., GRUBB, G.S., and ROSMAN, A.W. A multicenter clinical trial of a progestin-only oral contraceptive in lactating women. Contraception 47(1): 23-35. January 1993.
70. EINARSON, T.R., KOREN, G., MATTICE, D., and SCHECHTER-TSAFRIRI, O. Maternal spermicide use and adverse reproductive outcome: A meta-analysis. American Journal of Obstetrics and Gynecology 162: 655-660. 1990.
71. ELIAS, C.J. and HEISE, L.L. Challenges for the development of female-controlled vaginal microbicides. AIDS 8: 1-9. 1994.
72. EMERLING, J.M., PALOZZI, P., LELVA, J., and COLLINS, U. Subdermal contraceptive implants in nurse-midwifery practice. Journal of Nurse-Midwifery 38(2, Suppl.): 80S-87S. March-April 1993.
73. EREN, V., RAMOS, R., and GRAY, R.H. Physicians vs. auxiliary nurse-midwives as providers of IUD services: A study in Turkey and the Philippines. Studies in Family Planning 14: 43-47. 1983.
74. EUROPEAN NATURAL FAMILY PLANNING STUDY GROUPS. Prospective European multi-center study of Natural Family Planning (1989-1992): Interim results. Advances in Contraception 9(4): 269-283. December 1993.
75. FAMILY HEALTH INTERNATIONAL (FHI). New simplified OC instructions. Research Triangle Park, North Carolina, FHI, April 1992.
76. FARLEY, T.M., ROSENBERG, M.J., ROWE, P.J., CHEN, J.H., and MEIRIK, O. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 339(8796): 785-788. March 28, 1992.
77. FARR, G. and RIVERA, R.. Interactions between intrauterine contraceptive devices use and breastfeeding status at time of intrauterine contraceptive device insertion: Analysis of TCu-380A acceptors in developing countries. Advances in Contraception 167(1): 144-151. 1992.
78. FAÚNDES, A., ALVAREZ-SANCHEZ, F., BRACHE, V., JIMENEZ, E., and TEJADA, A.S. Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implants. Advances in Contraception 7(1): 85-94. 1991.
79. FELDBLUM, P. and JOANIS, C.. Modern barrier methods: Effective contraception and disease prevention. Research Triangle Park, North Carolina, Family Health International, 1994.
80. FELDBLUM, P.J., MORRISON, C.S., RODDY, R.E., and CATES, W., Jr. The effectiveness of barrier methods of contraception in preventing the spread of HIV. AIDS 9(Suppl. A): S85-S93. 1995.
81. FELDBLUM, P.J. and WEIR, S.S. The protective effect of nonoxynol-9 against HIV infection. [Letter] American Journal of Public Health 84: 1032-1034. 1994.
82. FERREIRA, A.E., ARAUJO, M.J., REGINA, C.H., DINIZ, S.G., and FAÚNDES, A. Effectiveness of the diaphragm, used continuously, without spermicide. Contraception 48: 29-35. 1993.
83. FIELD, C.S. Dysfunctional uterine bleeding. Primary Care 15(3): 561-574. 1988.
84. FLYNN, A.M. and LYNCH, S.S. Cervical mucus and identification of the fertile phase of the menstrual cycle. British Journal of Obstetrics and Gynaecology (83): 656-659. 1976.
85. FOTHERBY, K. Interactions with oral contraceptives. American Journal of Obstetrics and Gynecology 163: 2153-2159. 1990.
86. FOTHERBY, K. The progestin-only pill and thrombosis. British Journal of Family Planning 15: 83-85. 1989.
87. FOTHERBY, K., KOETSAWANG, S., and MATHRUBUTHAM, M. Pharmacokinetic study of different doses of Depo Provera. Contraception 22(5): 528-536. 1980.
88. FOX, M. Vasectomy reversal—Microsurgery for best results. British Journal of Urology 73: 449-453. 1994.
89. FOXMAN, B. and CHI, J.-W. Health behavior and urinary tract infection in college-aged women. Journal of Clinical Epidemiology 43: 329-337. 1990.
90. FRANK-HERRMANN, P., FREUNDL, G., BAUR, S., et al. Effectiveness and acceptability of the symptothermal method of Natural Family Planning in Germany. American Journal of Obstetrics and Gynecology 165: 2052-2054. 1991.
91. FRASER, I. Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Contraception 49(4): 399-420. April 1994.
92. GABBAY, M. and GIBBS, A. Does additional lubrication reduce condom failure? Contraception 53(3): 155-158. March 1996.
93. GARZA-FLORES, J. Pharmacokinetics of once-a-month injectable contraceptives. Contraception 49: 347-359. 1994.
94. GARZA-FLORES, J., HALL, P.E., and PEREZ-PALACIOS, G. Long-acting hormonal contraceptives for women. Journal of Steroid Biochemistry and Molecular Biology 40(4-6): 697-704. 1991.
95. GARZA-FLORES, J., VAZQUEZ-ESTRADA, L., REYES, A., et al. Assessment of luteal function after surgical tubal sterilization. Advances in Contraception 7: 371-377. 1991.
96. GIOVANNUCCI, E., ASCHERIO, A., RIMM, E.B., COLDITZ, G.A., STAMPFER, M.J., and WILLETT, W.C. A prospective cohort study of vasectomy and prostate cancer in US men. Journal of the American Medical Association 269: 873-877. 1993.
97. GIOVANNUCCI, E., TOSTESON, T.D., SPEIZER, F.E., ASCHERIO, A., VESSEY, M.P., and COLDITZ, G.A. A retrospective cohort study of vasectomy and prostate cancer in US men. Journal of the American Medical Association 269: 878-882. 1993.
98. GIWA-OSAGIE, O. and WORLD HEALTH ORGANIZATION. TASK FORCE ON LONG-ACTING SYSTEMIC AGENTS FOR FERTILITY REGULATION. Metabolic effects of once-a-month combined injectable contraceptives. Contraception 49(5): 421-433. May 1994.
99. GLOCK, J., KIM, A., HULKA, J., et al. Reproductive outcomes after tubal reversal in women 40 years of age or older. Fertility and Sterility 65(4): 863-865. 1996.
100. GOEMAN, J., NDOYE, I., SAKHO, L.M., et al. Frequent use of menfegol spermicidal vaginal foaming tablets associated with a high incidence of genital lesions. Journal of Infectious Diseases 171(6): 1611-1614. June 1995.
101. GRAY, R. Natural Family Planning and sex selection: Fact or fiction? American Journal of Obstetrics and Gynecology 165(Pt. 2, Suppl. 6): 1982-1984. 1991.
102. GRAY, R., CAMPBELL, O., ESLAMI, S., ZACUR, H., LABBOK, M., and APELO, R. The return of ovarian function during lactation: Results of studies from the United States and the Philippines. In: Gray, R., ed. Biomedical and demographic determinants of reproduction. Oxford, UK, Clarendon Press, 1993.
103. GRAY, R., SIMPSON, J., and KAMBIC, R. Timing of conception and the risk of spontaneous abortion among pregnancies occurring during the use of Natural Family Planning. American Journal of Obstetrics and Gynecology 172(5): 1567-1572. 1995.
104. GRAY, R.H., PARDTHAISONG, T., MCDANIEL, E.B., and DOYLE, P. The timing of the first injection of Depo Provera. IPPF Medical Bulletin 9(3): 3-4. 1975.
105. GROU, F. and RODRIGUES, I. The morning-after pill—How long after? American Journal of Obstetrics and Gynecology 171: 1529-1534. 1994.
106. GUILLEBAUD, J. Contraception for women over 35 years of age. British Journal of Family Planning 17: 115-118. 1992.
107. GUILLEBAUD, J. The forgotten pill—And the paramount importance of the pill free week. British Journal of Family Planning 12: 35-43. 1987.
108. GUPTA, K.C., JOSHI, J.V., DESAI, N.K., SANKOLLI, G.M., CHOWDHARY, V.N., JOSHI, U.M., CHITALANGE, S., and SATOSKAR, R.S. Kinetics of chloroquine and contraceptive steroids in oral contraceptive users during concurrent chloroquine prophylaxis. Indian Journal of Medical Research 80: 658-662. 1984.
109. HALL, P.E. Long-acting injectable formulations. In: Diczfalusy, E. and Bygdeman, M., eds. Fertility regulation today and tomorrow. New York, Raven Press, 1987. p 119.
110. HANENBERG, R.S., ROJANAPITHAYAKORN, W., KUNASOL, P., and SOKAL, D.S. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 344(8917): 243-245. July 23, 1994.
111. HAREL, Z., BIRO, F.M., and KOLLAR, L.M. Depo Provera in adolescents: Effects of early second injection or prior oral contraception. Journal of Adolescent Health 16: 379-384. 1995.
112. HARLAP, S. Exposure to contraceptive hormones through breast milk—Are there long-term health consequences? International Journal of Gynaecology and Obstetrics 25(Suppl): 47-55. 1987.
113. HARRISON, H.R., COSTIN, M., MEDER, J.B., BOWDS, L.M., SIM, D.A., LEWIS, M., and ALEXANDER, E.R. Cervical chlamydia trachomatis infection in university women: Relationship to history, contraception, ectopy and cervicitis. American Journal of Obstetrics and Gynecology 153(3): 244-251. 1985.
114. HATCHER, R., TRUSSELL, J., STEWART, F., et al. The diaphragm, contraceptive sponge, cervical cap, and female condom. and Fertility awareness. Contraceptive Technology. 16th rev. ed. New York, Irvington Publishers, 1994. p. 191-222. and 327340.
115. HEALY, B. Does vasectomy cause prostate cancer? From the National Institutes of Health. Journal of the American Medical Association 269(20): 2620. May 26, 1993.
116. HENSHAW, S.K. and SINGH, S. Sterilization regret among U.S. couples. Family Planning Perspectives 18: 238-240. 1986.
117. HERBST, A.L., MISHELL, D.R., STENCHEVER, M.A., and DROEGEMUELLER, W. Comprehensive gynecology. St. Louis, Missouri, Mosby-Year Book, 1992. p. 1082-1083.
118. HOOTON, T.M., HILLIER, S., JOHNSON, C., ROBERTS, P.L., and STAMM, W.E. Escherichia coli bacteriuria and contraceptive method. Journal of the American Medical Association 265: 64-69. 1991.
119. HOWIE, P.W., FORSYTH, J.S., OGSTON, S.A., CLARK, A., and FLOREY, C. Protective effect of breast feeding against infection. British Medical Journal 300(6716): 11-16. January 6, 1990.
120. HOWIE, P.W., MCNEILLY, A.S., HOUSTON, M.J., COOK, A., and BOYLE, H. Fertility after childbirth: Postpartum ovulation and menstruation in bottle and breast feeding mothers. Clinical Endocrinology 17: 323-332. 1982.
121. HUBER, D.H. Voluntary surgical contraception. In: Hatcher, R.A., Kowal, D., Guest, F., et al., eds. Contraceptive technology: International edition. Special section on AIDS. Atlanta, Georgia, Printed Matter, 1989.
122. HUBER, D.H. and HUBER, S.C. Screening oral contraceptive candidates and inconsequential pelvic examinations. Studies in Family Planning 6(2): 49-51. 1975.
123. HUFFMAN, S.L. Material malnutrition and breastfeeding: Is there really a choice for policy makers? Journal of Tropical Pediatrics 37(Suppl): 19-22. 1991.
124. HUNT, W.L., GABBAY, L., and POTTS, M. Lea's Shield, a new barrier contraceptive: Prelminary clinical evaluations three-day tolerance study. Contraception 50(6): 551-561. December 1994.
125. ILARIA, G., JACOBS, J.L., POLSKY, B., et al. Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. [Letter] Lancet 340: 1469. 1992.
126. INSLER, V., MELMED, H., EICHENBRENNER, I., SERR, D., and LUNENFELD, B. The cervical score: A simple semiquantitative method for monitoring of the menstrual cycle. International Journal of Gynaecology and Obstetrics 10(6): 223-228. 1972.
127. INTERNATIONAL CENTER FOR MEDICAL RESEARCH TASK FORCE ON HORMONAL CONTRACEPTION. Return to fertility following discontinuation of an injectable contraceptive—NET-EN. Contraception 34(6): 573-582. 1986.
128. INTERNATIONAL PLANNED PARENTHOOD FEDERATION. INTERNATIONAL MEDICAL ADVISORY BOARD. Statement on emergency contraception. Planned Parenthood in Europe 24(2): 5-6. 1995.
129. INTRAH (Program for International Training in Health). Guidelines for clinical procedures in family planning: A reference for trainers. 2nd ed. Chapel Hill, North Carolina, INTRAH, 1993.
130. JACOBS, H.S., KNUTH, U.A., HULL, M.G.R., and FRANKS, S. Post-pill amenorrhea—Cause or coincidence? British Medical Journal 2(6092): 940-942. October 8, 1977.
131. JANOWITZ, B., DIGHE, N.M., HUBACHER, D., and PETRICK, T. Assessing the impact of reducing the number of IUD revisits. Presented at the 120th Annual Meeting of the American Public Health Association, Washington, D.C., November 8-12, 1992. 12 p.
132. JENNINGS, R. and CLEGG, A. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in vitro. Journal of Antimicrobial Chemotherapy 32: 71-82. 1993.
133. JICK, H., WALKER, A.M., ROTHMAN, K.J., et al. Vaginal spermicides and congenital disorders. Journal of the American Medical Association 245(13): 1329-1332. April 3, 1981.
134. KAMBIC, R. and GRAY, R. Factors related to autonomy and discontinuation of use of Natural Family Planning for women in Liberia and Zambia. American Journal of Obstetrics and Gynecology 165: 2060-2062. 1991.
135. KARIM, M., AMMAR, R., EL MAHGOUB, S., EL GANZOURY, B., FIKRI, F., and ABDOU, I. Injected progestogen and lactation. British Medical Journal 1: 200-203. January 23, 1971.
136. KASS-ANNESE, B., AUMACK, K., and GOODMAN, L. Guide for Natural Family Planning trainers. Los Angeles, Institute for International Studies in Natural Family Planning, 1990.
137. KAUNITZ, A.M. Injectable contraception. Clinical Obstetrics and Gynecology 32(2): 356-368. 1989.
138. KAZI, A., KENNEDY, K.I., VISNESS, C.M., and KHAN, T. Effectiveness of the Lactational Amenorrhea Method in Pakistan. Fertility and Sterility 64: 717-723. 1995.
139. KEITH, L. and BERGER, G.S. The etiology of pelvic inflammatory disease. Research Frontiers in Fertility Regulation 3(1): 1-16. 1984.
140. KELAGHAN, J., RUBIN, G.L., ORY, H.W., and LAYDE, P.M. Barrier-method contraceptives and pelvic inflammatory disease. Journal of the American Medical Association 248: 184-187. 1982.
141. KENNEDY, K.I. Breastfeeding and the double protection dilemma. Research Triangle Park, North Carolina, Family Health International, September 1991.
142. KENNEDY, K.I. Fertility, sexuality and contraception during lactation. In: Riordan, J. and Auerback, K., eds. Breastfeeding and human lactation. Boston, Jones and Bartlett, 1993.
143. KENNEDY, K.I. Post-partum contraception. [Review. 64 refs] Baillieres Clinical Obstetrics and Gynaecology 10(1): 25-41. April 1996.
144. KENNEDY, K.I., GROSS, B., PARENTEAU-CARREAU, S., et al. Breastfeeding and the symptothermal method. Studies in Family Planning 26(2): 107-115. 1995.
145. KENNEDY, K.I., LABBOK, M.H., and VAN LOOK, P.F.A. Consensus statement on the Lactational Amenorrhea Method for family planning. International Journal of Gynaecology and Obstetrics 54: 55-57. 1996.
146. KENNEDY, K.I., RIVERA, R., and MCNEILLY, A. Consensus statement on the use of breastfeeding as a family planning method. Contraception 39(5): 477-496. 1989.
147. KENNEDY, K.I. and VISNESS, C.M. Contraceptive efficacy of lactational amenorrhea. Lancet 339(8796): 227-230. March 28, 1992.
148. KESSERU-KOOS, E. Influence of various hormonal contraceptives on sperm migration in vivo. Fertility and Sterility 22: 584-603. 1971.
149. KESTELMAN, P. and TRUSSELL, J. Efficacy of the simultaneous use of condoms and spermicides. Family Planning Perspectives 23: 226-227, 232. 1991.
150. KILLICK, S.R., BANCROFT, K., OELBAUMS, M.J., and ELSTEIN, M. Extending the duration of the pill-free interval during combined oral contraception. Advances in Contraception 6: 33-40. 1990.
151. KJAEL, A., LAURSEN, K., THORMANN, L., BARGGAARD, O., and LEBECH, P. Copper release from copper intrauterine devices removed after up to 8 years of use. Contraception 47(4): 349-350. April 1993.
152. KOETSAWANG, S. Once-a-month injectable contraceptives: Efficacy and reasons for discontinuation. Contraception 49(4): 387-398. April 1994.
153. KORBA, V.D. and PAULSON, S.R. Five years of fertility control with microdose norgestrel: An updated clinical review. Journal of Reproductive Medicine 13(2): 71-75. August 1974.
154. KRAMER, D. and BROWN, S. Sexually transmitted diseases and infertility. International Journal of Gynaecology and Obstetrics 22: 19-27. 1984.
155. KREISS, J., NGUGI, E., HOLMES, K., et al. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. Journal of the American Medical Association 268: 477-482. 1992.
156. LABBOK, M., COONEY, K., and COLY, S. Guidelines: Breastfeeding, family planning, and the Lactational Amenorrhea Method—LAM. Washington, D.C., Institute for Reproductive Health, 1994.
157. LABBOK, M. and KRASOVEC, K. Toward consistency in breastfeeding definitions. Studies in Family Planning 21: 226-230. 1990.
158. LABBOK, M., PEREZ, A., VALDES, V., et al. The Lactational Amenorrhea Method: A new postpartum introductory family planning method. Advances in Contraception 10: 93-109. 1994.
159. LABBOK, M.H., PEREZ, A., VALDES, V., SEVILLA, F., WADE, K., LAUKARAN, V.H., COONEY, K.A., COLY, S., SANDERS, C., and QUEENAN, J.R. The Lactational Amenorrhea Method (LAM): A postpartum introductory family planning method with policy and program implications. Advances in Contraception 10: 93-109. 1994.
160. LADIPO, O.A., FARR, G., OTOLORIN, E., et al. Prevention of IUD-related pelvic infection: The efficacy of prophylactic doxycycline at IUD insertion. Advances in Contraception 7(1): 43-54. March 1991.
161. LÄHTEENMAKI, P. Oral contraception and immediate postabortion pituitary-ovarian function. Acta Obstetricia et Gynecologica 76(Suppl): 9-43. 1978.
162. LÄHTEENMAKI, P. Postabortal contraception. Annals of Medicine 25: 185-189. 1993.
163. LÄHTEENMAKI, P., TOIVONEH, J., RASI, V., LUUKKAINEN, T., and MYLLYÄ, G. Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion. American Journal of Obstetrics and Gynecology 141: 175-179. 1981.
164. LÄHTEENMAKI, P., YÖLSTALO, P., SIPINEN, S., TOIVONEN, J., RUUSUVAARA, L., PIKKOLA, P., NILSSON, C.G., and LUUKKAINEN, T. Return of ovulation after abortion and after discontinuation of oral contraceptives. Fertility and Sterility 34(3): 246-249. 1980.
165. LAING, J. Periodic abstinence in the Philippines: New findings from a national survey. Studies in Family Planning 18(1): 32-41. 1987.
166. LAMPRECHT, V. and GRUMMER-STRAWN, L. Development of new formulas to identify the fertile time of the menstrual cycle. Contraception 54(6): 339-343. 1996.
167. LANDE, R.E. and BLACKBURN, R. Pharmacists and family planning. Population Reports, Series J, No. 37. Baltimore, Johns Hopkins School of Public Health, Population Information Program, November 1989. 32 p.
168. LANDGREN, B.M. and EMICZKY, C.S. The effect on follicular growth and luteal function of "missing the pill." Contraception 43(2): 149-159. February 1991.
169. LAROS, R.K., Jr., ZATUCHNI, G.I., and ANDROS, G.J. Puerperal tubal ligation morbidity, histology, and bacteriology. Obstetrics and Gynecology 41: 397-403. 1973.
170. LASSISE, D.L., SAVITZ, D.A., HAMMAN, R.F., BARON, A.E., BRINTON, L.A., and LEVINES, R.S. Invasive cervical cancer and intrauterine device use. International Journal of Epidemiology 20(4): 865-870. 1991.
171. LEADER, A., GALAN, N., GEORGE, R., and TAYLOR, P. A comparison of definable traits in women requesting reversal of sterilization and women satisfied with sterilization. American Journal of Obstetrics and Gynecology 145: 198-202. 1983.
172. LEE, N.C., RUBIN, G.L., and BORUCKI, R. The intrauterine device and pelvic inflammatory disease revisited: New results from the women's health study. Obstetrics and Gynecology 72(1): 1-6. 1988.
173. LEE, N.C., RUBIN, G.L., ORY, H.W., and BURKMAN, R.T. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstetrics and Gynecology 62: 1-6. 1983.
174. LEITCH, W.S. Longevity of Gynol 2 and Ortho Creme in the Prentif cervical cap. Contraception 34: 363-379. 1986.
175. LEITCH, W.S. Longevity of Ortho Creme and Gynol 2 in the contraceptive diaphragm. Contraception 34: 381-393. 1986.
176. LEONARD, A.H. and LADIPO, O.A. Postabortion family planning: Factors in individual choice of contraceptive methods. Advances in Abortion Care 4(2): 1-4. 1994.
177. LIANG, A.P., LEVENSON, A.G., LAYDE, P.M., SHELTON, J.D., HATCHER, R.A., POTTS, M., and MICHELSON, M.J. Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. Journal of the American Medical Association 249: 2909-2912. 1983.
178. LISKIN, L., PILE, J.M., and QUILLIN, W.F. Vasectomy—Safe and simple. Population Reports, Series D, No. 4. Baltimore, Johns Hopkins School of Public Health, Population Information Program, November-December 1983. 40 p.
179. LOBO, R.A. and SPEROFF, L. International consensus conference on postmenopausal hormone therapy and the cardiovascular system. Fertility and Sterility 62: 1765-1795. 1994.
180. LOUV, W., AUSTIN, H., ALEXANDER, W., STAGNO, S., and CHEEKS, J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. Journal of Infectious Diseases 158(3): 518-522. 1988.
181. LUUKKAINEN, T., NIELSON, N.C., NYGREN, K.G., and PYORALA, T. Nulliparous women, IUD and pelvic infection. Annals of Clinical Research 11: 121-124. 1979.
182. MARCIL-GRATTON, N. Sterilization regret among women in metropolitan Montreal. Family Planning Perspectives 20: 222-227. 1988.
183. MARMAR, J. The status of vasectomy reversals. International Journal of Fertility 36(6): 352-357. 1991.
184. MASSEY, F.J., Jr., BERNSTEIN, G.S., O'FALLON, W.M., et al. Vasectomy and health: Results from a large cohort study. Journal of the American Medical Association 252: 1023-1029. 1984.
185. MATTSON, R.H. and REBAR, R.W. Contraceptive methods for women with neurologic disorders. American Journal of Obstetrics and Gynecology 168: 2027-2032. 1993.
186. MAUCK, C., GLOVER, L.H., MILLER, E., et al. Lea's Shield: A study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide. Contraception 53(6): 329-335. June 1996.
187. MCCANN, M.F., MOGGIA, A.V., HIGGINS, J.E., POTTS, M., and BEEKER, C. The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breastfeeding. Contraception 40(6): 635-648. 1989.
188. MCCANN, M.F. and POTTER, L.S. Progestin-only oral contraception: A comprehensive review. Contraception 50(6, Suppl. 1): S1-S95. December 1994.
189. MCINTOSH, N., KINZIE, B., and BLOUSE, A., eds. IUD guidelines for family planning service programs. 2nd ed. Baltimore, JHPIEGO Corporation, 1993.
190. MIALE, J.B. and KENT, J.W. The effects of oral contraceptives on the results of laboratory tests. American Journal of Obstetrics and Gynecology 120(2): 264-272. September 15, 1974.
191. MISHELL, D.R. Long-acting contraceptive steroids: Postcoital contraceptives and antiprogestins. In: Mishell, D.R., Davajan, V., and Lobo, R.A., eds. Infertility, contraception, and reproductive endocrinology. 3rd ed. Boston, Blackwell Scientific, 1991. p. 872-894.
192. MISHELL, D.R and ROY, S. Copper intrauterine contraceptive device event rates following insertion 4 to 8 weeks postpartum. American Journal of Obstetrics and Gynecology 143(1): 29-33. 1982.
193. MOGHISSI, K.S., SYNER, F.N., and EVANS, T.N. A composite picture of the menstrual cycle. American Journal or Obstetrics and Gynecology 114(3): 405-418. 1972.
194. MOGHISSI, K.S., SYNER, F.N., and MCBRIDE, L.C. Contraceptive mechanism of microdose norethindrone. Obstetrics and Gynecology 41: 585-594. 1973.
195. MOLLOY, B.G., COULSON, K.A., LEE, J.M., and WATTERS, J.K. "Missed pill" conception: Fact or fiction? British Medical Journal 290(6480): 1474-1475. May 18, 1985.
196. MORENO, L. and GOLDMAN, N. Contraceptive failure rates in developing countries: Evidence from the demographic and health surveys. International Family Planning Perspectives 17: 44-49. 1991.
197. MURPHY, A., ZACUR, H., CHARACHE, P., and BURKMAN, R. The effect of tetracycline on levels of oral contraceptives. American Journal of Obstetrics and Gynecology 164: 28-32. 1991.
198. NASELLO, M., CALLIHAN, D., MENPUS, M., and STEIGHIGEL, R. A solid-phase enzyme immunoassay (gonozzyme®) test for direct detection of Neisseria gonorrhoeae antigen in urogenital specimens from patients at a sexually transmitted disease clinic. Sexually Transmitted Diseases, October-December 1985. p. 198-202.
199. NEAMATALLA, G.S. and HARPER, P.B. Family planning counseling and voluntary sterilization. New York, AVSC International, 1990.
200. NIRUTHISARD, S., RODDY, R.E., and CHUTIVONGSE, S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 339(8806): 1371-1375. June 6, 1992.
201. NOERPRAMANA, N.-P. The Norplant removal training and service at Dr. Kariadi Hospital, Semarang, Indonesia. Advances in Contraception 7(4): 389-401. December 1991.
202. NORSIGIAN, J. Feminist perspective on barrier use. In: Mauck, C.K., Cordero, M., Gabelnick, H.L., Spieler, J.M., and Rivera, R., eds. Barrier contraceptives: Current status and future prospects. New York, Wiley-Liss, 1994.
203. O'HANLEY, K. and HUBER, D. Postpartum IUDs: Keys for success. Contraception 45: 351-361. 1992.
204. ORME, M. and BACK, D.J. Oral contraceptive steroids—Pharmacological issues of interest to the prescribing physician. Advances in Contraception 7: 325-331. 1991.
205. ORME, M., BACK, D.J., and BRECKENRIDGE, A.M. Clinical pharmacokinetics of oral contraceptive steroids. Clinical Pharmacokinetics 8: 95-136. 1983.
206. OSTIMEHIN, B.D., OTOLORIN, E.D., and LADIPO, O.A. Sequential hormone measurements after first trimester abortion for normal Nigerian women. Advances in Contraception 1(1): 83-90. 1985.
207. OVERSTREET, J.W., KATZ, D.F., and YANAGIMACHI, R. Sperm transport and capacitation. In: Sciarra, J.J., ed. Gynecology and obstetrics. Philadelphia, J.B. Lippincott, 1995.
208. OYELOLA, O.O. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Contraception 47: 445-454. 1993.
209. PAAVONEN, J., KOUTSKY, L.A., and KIVIAT, N. Cervical neoplasia and other STD-related genital and anal neoplasias. In: Holmes, K.K., Mårdh, P., Sparling, P.F., Wiesner, P.J., Cates, W., Lemon, S.M., and Stamm, W., eds. Sexually transmitted diseases. New York, McGraw-Hill, 1984. p. 561-592.
210. PARAZZINI, F., LA VECCHIA, C., BOCCIOLONE, L., and FRANCESHI, S. The epidemiology of endometrial cancer. Gynecologic Oncology 41: 1-16. 1991.
211. PARDTHAISONG, T. Return of fertility after use of the injectable contraceptive Depo Provera: Up-dated data analysis. Journal of Biosocial Science 16: 23. 1984.
212. PARDTHAISONG, T. and GRAY, R.H. In utero exposure to steroid contraceptives and outcome of pregnancy. American Journal of Epidemiology 134(8): 795-803. 1991.
213. PARDTHAISONG, T., YENCHIT, C., and GRAY, R. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. Contraception 45: 313-324. 1992.
214. PEREZ, A., LABBOK, M.H, and QUEENAN, J.T. Clinical study of the lactational amenorrhea method for family planning. Lancet 339(8799): 968-970. April 18, 1992.
215. PETERSEN, K.R., BROOKS, L., JACOBSEN, B., and SKOUKY, S.O. Intrauterine devices in nulliparous women. Advances in Contraception 7(4): 333-338. 1991.
216. PETERSON, H.B., XIA, Z., HUGHES, J.M., et al. The risk of pregnancy after tubal sterilization: Findings from the U.S. collaborative review of sterilization. American Journal of Obstetrics and Gynecology 174: 1161-1170. 1996.
217. PITAKTEPSOMBATI, P. and JANOWITZ, B. Sterilization acceptance and regret in Thailand. Contraception 44: 623-637. 1991.
218. POPULATION COUNCIL (PC). Copper T 380A intrauterine device is effective for 10 years. [News Release] New York, PC, September 27, 1994.
219. POPULATION COUNCIL (PC). Norplant levonorgestrel implants: A summary of scientific data. New York, PC, 1990. p. 2.
220. PRENTICE, A.M., GOLDBERG, G.R., and PRENTICE, A. Body mass index and lactation performance. European Journal of Clinical Nutrition 48: S78-S96. 1994.
221. PRITCHARD, J.A. and MACDONALD, P.C. Maternal adaptation to pregnancy. In: Williams obstetrics. 16th ed. New York, Appleton-Century-Crofts, 1990. p. 221-259.
222. PUDNEY, J., ONETA, M., MAYER, K., SEAGE, G., 3rd, and ANDERSON, D. Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. [Letter] Lancet 340: 1470. 1992.
223. PUGIN, E., VALDEZ, V., LABBOK, M., PEREZ, A., and ARAVENA, R. Does prenatal education contribute to the duration of full breastfeeding in a comprehensive breastfeeding promotion program? Journal of Human Lactation 12: 15-20. 1996.
224. QUINN, D.A., THAMPSON, B.R., TERRIN, M.L., THRALL, J.H., ATHANASOULIS, C.A., MCKUSICK, K.A., STEIN, P.F., and HATES, C.A. A prospective investigation of pulmonary embolism in women and men. Journal of the American Medical Association 268(13): 1689-1696. 1992.
225. RAMOS, R., KENNEDY, K.I., and VISNESS, C. Effectiveness of the Lactational Amenorrhea Method in preventing pregnancy in Manila, the Philippines. British Medical Journal 313: 909-912. 1996.
226. RIVERA, R., GAITAN, J., RUIZ, R., et al. Menstrual patterns and progesterone circulating levels following different procedures of tubal occlusion. Contraception 40(2): 157-169. 1989.
227. RODDY, R.E., CORDERO, M., CORDERO, C., and FORTNEY, J.A. A dosing study of nonoxynol-9 and genital irritation. International Journal of STD and AIDS 4(3): 165-170. May-June 1993.
228. ROGOW, D., RINTOUL, E., and GREENWOOD, S. A year's experience with a fertility awareness program: A report. Advances in Planned Parenthood 15(1): 27-33. 1980.
229. ROSENBERG, M., ROJANAPITHAYAKORN, W., FELDBLUM, P., and HIGGINS, J. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis: A comparative clinical trial. Journal of the American Medical Association 257: 2308-2312. 1987.
230. ROSENBERG, M.J. and GOLLUB, E.L. Commentary: Methods women can use that may prevent sexually transmitted disease, including HIV. American Journal of Public Health 82: 1473-1478. 1992.
231. ROSENFIELD, A., MAINE, D., and GOROSH, M.E. Nonclinical distribution of the pill in the developing world. International Family Planning Perspectives 6(4): 130-135. 1980.
232. ROSS, J., HONG, S., and HUBER, D. Voluntary sterilization: An international fact book. New York, AVSC, 1985.
233. ROUZI, A., MACKINNON, M., and MCCOMB, P. Predictors of success of reversal of sterilization. Fertility and Sterility 64(1): 29-36. 1995.
234. RULIN, M.C., DAVIDSON, A.R., PHILLIBER, S.G., GRAVES, W.L., and CUSHMAN, L.F. Changes in menstrual symptoms among sterilized and comparison women: A prospective study. Obstetrics and Gynecology 74: 149-154. 1989.
235. SANG, G. Pharmacodynamic effects of once-a-month combined injectable contraceptives. Contraception 49(4): 361-385. 1994.
236. SANTELLI, J.S., BURWELL, L.G., ROZSENICH, C., et. al. Surgical sterilization among women and use of condoms—Baltimore, 1989-1990. Morbidity and Mortality Weekly Report 41: 568-575. 1992.
237. SARACCO, A., MUSICCO, M., NICOLOSI, A., et. al. Man-to-woman sexual transmission of HIV: Longitudinal study of 343 steady partners of infected men. Journal of Acquired Immune Deficiency Syndrome 6: 497-502. 1993.
238. SCHIPHORST, L.E., COLLINS, W.P., and ROYSTAR, J.P. An estrogen test to determine the times of potential fertility in women. Fertility and Sterility 44: 328-334. 1985.
239. SCHWALLIE, P.C. and ASSENZO, J.R. The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: A review. Contraception 10(4): 181-202. 1974.
240. SECOR, R. The Cervical Cap. NAACOG's Clinical Issues in Perinatal and Women's Health Nursing 3(2): 236-245. 1992.
241. SHAABAN, M., SALEM, H., and ABDULLAH, K. Influence of levonorgestrel contraceptive implants, Norplant, initiated early postpartum upon lactation and infant growth. Contraception 32(6): 623-635. 1985.
242. SHAABAN, M.M. Contraception with progestogens and progesterone during lactation. Journal of Steroid Biochemistry and Molecular Biology 40(4-6): 705-710. 1991.
243. SHAIN, R.N., MILLER, W.B., and HOLDEN, A.E.C. Married women's dissatisfaction with tubal sterilization and vasectomy at first-year follow-up: Effects of perceived spousal dominance. Fertility and Sterility 45: 808-819. 1986.
244. SHELTON, J.D., ANGLE, M.A., and JACOBSTEIN, R.A. Medical barriers to access to family planning. Lancet 340(8831): 1334-1335. November 28, 1992.
245. SHELTON, J.D. and HARRIS, J.R. Role of the condom in combatting global AIDS: The application of Sutton's law to public health. In: Alexander, N.J., Gabelnick, H.L., and Spieler, J.M., eds. Heterosexual transmission of AIDS: Proceedings of the Second Contraceptive Research and Development (CONRAD) Program International Workshop, Norfolk, Virginia, February 1-3, 1989.
246. SHERRIS, J.D., RAVENHOLT, B.B., BLACKBURN, R., GREENBERG, R.H., KAK, N., PORTER, R.W., 3rd, and SAUNDERS, S. Contraceptive social marketing: Lessons from experience. Population Reports, Series J, No. 30. Baltimore, Johns Hopkins School of Public Health, Population Information Program, July-August 1985. 40 p.
247. SHOUPE, D. Injectable contraceptives and contraceptive vaginal rings. In: Shoupe, D. and Haseltine, F.P., eds. Contraception. New York, Springer-Verlag, 1993. p 144-157.
248. SHOUPE, D., MISHELL, D.R., BOPP, B.L., and FIELDING, M. The significance of bleeding patterns in Norplant implant users. Obstetrics and Gynecology 77: 256-260. 1991.
249. SIDNEY, S., QUESENBERRY, C.P., Jr., SADLER, M.C., GUESS, H.A., LYDICK, E.G., and CATTOLICA, E.V. Vasectomy and the risk of prostate cancer in a cohort of multiphasic health-checkup examinees: Second report. Cancer Causes and Control 2(2): 113-116. March 1991.
250. SIEGLER, A., HULKA, J., and PERETZ, A. Reversibility of female sterilization. Fertility and Sterility 43(4): 499-510. 1985.
251. SIMPSON, J.L. and PHILLIPS, O.P. Spermicides, hormonal contraception and congenital malformations. Advances in Contraception 6: 141-167. 1990.
252. SINEI, S., SCHULZ, K., LAMPTEY, P., et. al. Preventing IUCD-related pelvic infection. British Journal of Obstetrics and Gynaecology 97: 412-419. 1990.
253. SINGH, K., VIEGAS, O.A.C., and RATNAM, S.S. A three-year evaluation of Norplant in Singaporean acceptors. Advances in Contraception 6: 1-9. 1990.
254. SIVIN, I. International experience with Norplant and Norplant-2 contraceptives. Studies in Family Planning 19(2): 81-94. March-April 1988.
255. SIVIN, I., DIAZ, S., HOLMA, P., ALVAREZ-SANEUEZ, F., and ROBERTSON, D.N. A four-year clinical study of Norplant. Studies in Family Planning 14(6-7): 184-191. 1983.
256. SMITH, C., FARR, M.G., FELDBLUM, P.J., and SPENCE, A. Effectiveness of the non-spermicidal fit-free diaphragm. Contraception 51(5): 289-291. May 1995.
257. SMITH, S.K., KIRKMAN, R.J.E., ARCE, B.B., MCNEILLY, A.S., LOUDON, N.B., and BAIRD, D.T. The effect of deliberate omission of Trinordiol® or Microgynon® on the hypothalamo-pituitary-ovarian axis. Contraception 34(5): 513-522. 1986.
258. SOLHEIM, F. An assessment of quality of life in women treated with Depo-Provera in Sweden. In: Zambrano, D., ed. Depo-Provera® (medroxyprogesterone acetate) for contraception: A current perspective of scientific, clinical and social issues. Kalamazoo, Michigan, Upjohn, 1992. p. 61-72.
259. SOPER, D.E., SHOUPE, D., SHANGOLD, G.A., SHANGOLD, M.M., GUTMANN, J., and MERCER, L. Prevention of vaginal trichomoniasis by compliant use of the female condom. Sexually Transmitted Diseases 20: 137-139. 1993.
260. SPARROW, M.J. Pregnancies in reliable pill takers. New Zealand Medical Journal 102(879): 575-577. 1989.
261. SPEROFF, L. and DARNEY, P. A clinical guide for contraception. Baltimore, Williams & Wilkins, 1996.
262. SPEROFF, L., GLASS, R.H., and KASE, N.G. Clinical gynecologic endocrinology and infertility. 4th ed. Baltimore, Williams and Wilkins. 1989.
263. STANFORD, J.L. and THOMAS, D.B. Exogenous progestins and breast cancer. Epidemiologic Review 15(1): 98-107. 1993.
264. STEIN, Z. More on women and the prevention of HIV infection. [Editorial] American Journal of Public Health 85: 1485-1488. 1995.
265. STEINER, M., PIEDRAHITA, C., GLOVER, L., and JOANIS, C. Can condom users likely to experience condom failure be identified? Family Planning Perspectives 25(5): 220-223, 226. September-October 1993.
266. STIM, E.M. The nonspermicide fit-free diaphragm: A new contraceptive method. Advances in Planned Parenthood 15(3): 88-98. 1980.
267. SWEET, R.L., DRAPER, D.L., and HADLEY, W.K. Etiology of acute salpingitis: Influence of episode number and duration of symptoms. Obstetrics and Gynecology 58: 62-68. 1981.
268. TATUM, H.J. and CONNELL, E.B. A decade of intrauterine contraception: 1976-1986. Fertility and Sterility 46(2): 173-192. August 1986.
269. TECHNICAL GUIDANCE/COMPETENCE WORKING GROUP. Recommendations for updating selected practices in contraceptive use. Vol. 2. Chapel Hill, North Carolina, Program for International Training in Health, 1997.
270. TECHNICAL GUIDANCE WORKING GROUP. Recommendations for updating selected practices in contraceptive use: Results of a technical meeting. Vol. 1. Chapel Hill, North Carolina, Program for International Training in Health, November 1994.
271. THEINTZ, G., BUCHS, B., RIZZOLI, R., SLOSMAN, D., CLAVIEN, H., SIZONENKO, P.C., and BONJOUR, J.P. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. Journal of Clinical Endocrinology and Metabolism 75: 1060-1065. 1992.
272. TIETJEN, L., CRONIN, W., and MCINTOSH, N. Infection prevention for family planning service programs: A problem-solving reference manual. Durant, Oklahoma, Essential Medical Information Systems, 1992.
273. TRUSSELL, J., ELLERTSON, C., and RODRIGUEZ, G. The Yuzpe regimen of emergency contraception: How long after the morning after? Obstetrics and Gynecology 88: 150-154. 1996.
274. TRUSSELL, J., ELLERTSON, C., and STEWART, F. The effectiveness of the Yuzpe regimen of emergency contraception. Family Planning Perspectives 28: 58-64, 87. 1996.
275. TRUSSELL, J. and GRUMMER-STRAWN, L. Contraceptive failure of the ovulation method of periodic abstinence. Family Planning Perspectives 22: 65-75. 1990.
276. TRUSSELL, J. and KOST, K. Contraceptive failure in the United States: A critical review of the literature. Studies in Family Planning 18(5): 237-283. 1987.
277. TRUSSELL, J. and STEWART, F. The effectiveness of postcoital hormonal contraception. Family Planning Perspectives 24(6): 262-264. 1992.
278. TRUSSELL, J., STRICKLER, J., and VAUGHAN, B. Contraceptive efficacy of the diaphragm, the sponge and the cervical cap. Family Planning Perspectives 25(3): 100-105, 135. May-June 1993.
279. TRUSSELL, J., STURGEN, K., STRICKLER, J., and DOMINIK, R. Comparative contraceptive efficacy of the female condom and other barrier methods. Family Planning Perspectives 26: 66-72. 1994.
280. TSIBRIS, J.C.M. Cervical mucus. In: Gould, J.J. and Josimovich, J.B., eds. Gynecologic endocrinology. New York, Plenum, 1987. p. 175-183.
281. UNITED STATES. CENTERS FOR DISEASE CONTROL. Update: Barrier protection against HIV infection and other sexually transmitted diseases. Morbidity and Mortality Weekly Report 42: 589-591, 597. 1993.
282. UNITED STATES. FOOD AND DRUG ADMINISTRATION. FERTILITY AND MATERNAL HEALTH DRUGS ADVISORY COMMITTEE. Depo-Provera C-150 NDA 20-246. [Brochure] 1992. p. 37.
283. VICTORA, C.G., SMITH, P.G., VAUGHAN, J.P., et al. Infant feeding and deaths due to diarrhea: A case-control study. American Journal of Epidemiology 129(5): 1032-1041. 1987.
284. VICTORA, C.G., VAUGHAN, J.P., LOMBARDI, C., et al. Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet 2(8554): 319-322. August 8, 1987.
285. VISNESS, C. and RIVERA, R. Progestin-only pill use and pill switching during breastfeeding. Contraception 51: 279-281. 1995.
286. VOELLER, B., COULSON, A.H., BERNSTEIN, G.S., and NAKAMURA, R.M. Mineral oil lubricants cause rapid deterioration of latex condoms. Contraception 39(1): 95-101. January 1989.
287. WALSH, T., BERNSTEIN, G., GRIMES, D., et. al. Effect of prophylactic antibiotics on morbidity associated with IUD insertion: Results of a pilot randomized controlled trial. Contraception 50: 319-327. 1994.
288. WANG, S.C., WU, S.C., XIN, X.M., CHEN, J.H., and GAO, J. Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: A randomized comparative study. Advances in Contraception 8(2): 105-111. 1992.
289. WARD, R.M. Pharmacologic principles and practicalities. In: Taeusch, H.W., Ballard, R.A., and Avery, M.E., eds. Diseases of the newborn. Philadelphia, WB Saunders, 1991.
290. WEBB, A. Emergency contraception. Fertility Control Reviews 4(2): 3-7. 1995.
291. WEBB, A. How safe is the Yuzpe method of emergency contraception? Fertility Control Reviews 4(2): 16-18. 1995.
292. WEBB, A. When to use post-coital contraception. Fertility Control Reviews 2(2): 15-17. 1992.
293. WEIR, S.S., FELDBLUM, P.J., ZEKENG, L., and RODDY, R.E. The use of nonoxynol-9 for protection against cervical gonorrhea. American Journal of Public Health 84: 910-914. 1994.
294. WESTÖRM, L. and MÅRDH, P. Acute pelvic inflammatory disease (PID). In: Holmes, K.K., Mårdh, P., Sparling, P.F., Wiesner, P.J., Cates, W., Lemon, S.M., and Stamm, W., eds. Sexually transmitted diseases. 2nd ed. New York, McGraw-Hill, 1990. p. 596-613.
295. WILCOX, L.S., CHU, S.Y., EAKER, E.D., ZEGER, S.L., and PETERSON, H.B. Risk factors for regret after tubal sterilization: 5 years of follow-up in a prospective study. Fertility and Sterility 55: 927-933. 1991.
296. WILEY, A. The diaphragm. In: Corson, S., Derman, R., and Tyrer, L., eds. Fertility control. Boston, Little, Brown & Company, 1985. p. 223-232.
297. WILSON, E.S.B., CRUICKSHANK, J., MCMASTER, M., and WEIR, R.J. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. British Journal of Obstetrics and Gynaecology 91(12): 1254-1260. December 1984.
298. WISEMAN, R.A. and DODDS-SMITH, I.C. Cardiovascular birth defects and antenatal exposure to female sex hormones: A re-evaluation of some base data. Teratology 30(3): 359-370. 1984.
299. WORLD FEDERATION OF HEALTH AGENCIES FOR THE ADVANCEMENT OF VOLUNTARY SURGICAL CONTRACEPTION (AVSC). Safe and voluntary surgical contraception: Guidelines for service programs. New York, AVSC, 1988. 119 p.
300. WORLD HEALTH ORGANIZATION. Facts about once-a-month injectable contraceptives: Memorandum from a WHO meeting. Bulletin of the World Health Organization 71(6): 677-689. 1993.
301. WORLD HEALTH ORGANIZATION (WHO). Female sterilization: A guide to provision of services. Geneva, WHO, 1992.
302. WORLD HEALTH ORGANIZATION (WHO). Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use. Geneva, WHO, 1996.
303. WORLD HEALTH ORGANIZATION (WHO). Injectable contraceptives: Their role in family planning care. Geneva, WHO, 1990. 127 p.
304. WORLD HEALTH ORGANIZATION (WHO). A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100mg or 150mg: 1. Contraceptive efficacy and side effects. Contraception 34(3): 223-235. 1986.
305. WORLD HEALTH ORGANIZATION (WHO). Natural Family Planning: A guide to provision of services. Geneva, WHO, 1988.
306. DORIG, B.T. and GREENSLADE, F.C. Norplant contraceptive subdermal implants: Managerial and technical guidelines. Geneva, World Health Organization, 1990. 140 p.
307. WORLD HEALTH ORGANIZATION (WHO). A prospective multicentre trial of the ovulation method of Natural Family Planning: 1. The teaching phase. Fertility and Sterility 36(2): 152-158. 1981.
308. WORLD HEALTH ORGANIZATION (WHO). and BLAT CENTRE FOR HEALTH AND MEDICAL EDUCATION. Family fertility education: A resource package for teachers of Natural Family Planning methods. Geneva, WHO, 1982.
309. WORLD HEALTH ORGANIZATION (WHO). FAMILY PLANNING AND POPULATION DIVISION OF FAMILY HEALTH. Providing an appropriate contraceptive method choice: What health workers need to know. Geneva, WHO, 1993. p. 41.
310. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT, AND RESEARCH TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON ORAL CONTRACEPTIVES. Effects of hormonal contraceptives on breast milk composition and infant growth. Studies in Family Planning 19(6): 361-369. 1988.
311. WORLD HEALTH ORGANIZATION (WHO). SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. SCIENTIFIC WORKING GROUP. Improving access to quality care in family planning: Medical eligibility criteria for initiating and continuing use of contraceptive methods. Geneva, WHO, 1995.
312. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT, AND RESEARCH TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON ORAL CONTRACEPTIVES. Effects of hormonal contraceptives on milk volume and infant growth. Contraception 30(6): 505-521. 1984.
313. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. Multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception 28(1): 1-21. 1983.
314. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON INTRAUTERINE DEVICES. PID associated with fertility regulating agents. Contraception 30(1): 1-21. 1984.
315. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON FEMALE STERILIZATION. Mini-incision for post-partum sterilization of women: A multicenter, multinational prospective study. Contraception 26: 495-503. 1982.
316. WORLD HEALTH ORGANIZATION. TASK FORCE ON LONG-ACTING SYSTEMIC AGENTS FOR FERTILITY REGULATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. Amulticentred phase 3 comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: 1. Contraceptive efficacy and side effects. Contraception 37: 1-20. 1988.
317. WRIGHT, S.W., FOTHERBY, K., and FAIRWEATHER, F. Effect of daily small doses of norgestrel on ovarian function. Journal of Obstetrics and Gynaecology of the British Commonwealth 77: 65-68. January 1970.
318. XU, J., CONNELL, C., and CHI, I. Immediate postplacental insertion of the intrauterine device: A review of Chinese and the world's experiences. Advances in Contraception 10: 71-82. 1992.
319. ZACHARIAS, S., AGUILERA, E., ASSENZO, J.R., and ZANARTU, J. Effects of hormonal and non-hormonal contraceptives on lactation and incidence of pregnancy. Contraception (3): 203-213. 1986.
320. ZAVALA, A.S., PEREZ-GONZALES, M., MILLER, P., WELSH, M., WILKENS, L.R., and POTTS, M. Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico. Studies in Family Planning 18(5): 284-290. 1987.
321. ZEKENG, L., FELDBLUM, P.J., GODWIN, S.E., OLIVER, R.M., and KAPTUE, L. HIV infection and barrier contraceptive use among high-risk women in Cameroon. AIDS 7: 725-731. 1993.
322. ZHOU, S. and CHI, I. Immediate post-partum IUD insertions in a Chinese hospital—A two year follow-up. International Journal of Gynaecology and Obstetrics 35: 157-164. 1991.
323. ZHU, K., STANFORD, J.L., DALING, J.R., MCKNIGHT, B., STERGACHI, S., BRAWER, M.K., and WEISS, N.S. Vasectomy and prostate cancer: A case-control study in a health maintenance organization. American Journal of Epidemiology 144: 717-722. 1996.
324. ZINAMAN, M., HUGHES, V., QUEENAN, J., et al. Acute prolactin, oxytocin response and milk yield to infant suckling and artificial methods of expression in lactating women. Pediatrics 89: 437-440. 1992.
325. ZORLU, C., ARAL, K., COBANOGLU, O., GURLER, S., and GOKMEN, O. Pelvic inflammatory disease and intrauterine devices. Advances in Contraception 9: 299-302. 1993.